Search Results 1511-1520 of 14758 for anti-TNF drugs

1. Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY) - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... deoxyribonucleic acid antibody seropositivity or anti-citrullinated ...

2. New breast cancer drug is 'very exciting'

   "While the primary goal of the study was to safely deliver therapeutic levels of endoxifen, one of the most surprising observations was the prolonged anti ...

3. Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Stage IV Non-Small Cell Lung Cancer Patients Who Are PD-L1 Negative - Mayo Clinic

   usual treatment alone in treating patients with non-small cell lung cancer that has spread to nearby tissue or lymph nodes (advanced) or has spread to other ...

4. Coagulation Factor Viia (Intravenous Route) Before Using - Mayo Clinic

   ... medicines. Anti-Inhibitor Coagulant Complex; Factor XIII; Prothrombin Complex. Other Interactions. Certain medicines should not be used at or around the time of ...

5. HER2-Positive Breast Cancer Clinical Trials - Mayo Clinic Research

   The primary objective of this study is to demonstrate that the combination of palbociclib with anti-HER2 therapy plus endocrine therapy is superior to anti-HER2 ...

6. Head and Neck Cancer Center - Overview - Mayo Clinic

   However, depending on your needs, you may also have access to other drug therapies, such as immunotherapy and targeted drug therapy. Rehabilitation and overall ...

7. Best Available Therapy Versus Autologous Hematopoetic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS) - Mayo Clinic

   About this study. The purpose of this trial is to compare the treatment strategy of Autologous Hematopoietic Stem Cell Transplantation (AHSCT) to the ...

8. Role of Immunity in Efficacy of Chemotherapy Plus Trastuzumab - Mayo Clinic

   Participation eligibility · Age >18 years. · Histological confirmation of clinically HER2+ breast cancer · Scheduled to start anti-HER2 therapy, in combination ...

9. Phase 2b Study of Investigational Products in Participants with Interstitial Lung Disease Secondary to Systemic Sclerosis - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... anti-CD19, and anti-CD20 agents; and investigational agents. Treatment with ...

10. A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease - Mayo Clinic

    ... anti-coagulant medication within 90 days of LP. NOTE: low dose aspirin is permitted); degenerative arthritis of the lumbar spine; suspected non ...